Literature DB >> 25585963

Oscillation of cAMP and Ca(2+) in cardiac myocytes: a systems biology approach.

Takehisa Kamide1, Satoshi Okumura, Samik Ghosh, Yoko Shinoda, Yasumasa Mototani, Yoshiki Ohnuki, Huiling Jin, Wenqian Cai, Kenji Suita, Itaru Sato, Masanari Umemura, Takayuki Fujita, Utako Yokoyama, Motohiko Sato, Kazuharu Furutani, Hiroaki Kitano, Yoshihiro Ishikawa.   

Abstract

Cyclic adenosine monophosphate (cAMP) and Ca(2+) levels may oscillate in harmony within excitable cells; a mathematical oscillation loop model, the Cooper model, of these oscillations was developed two decades ago. However, in that model all adenylyl cyclase (AC) isoforms were assumed to be inhibited by Ca(2+), and it is now known that the heart expresses multiple AC isoforms, among which the type 5/6 isoforms are Ca(2+)-inhibitable whereas the other five (AC2, 3, 4, 7, and 9) are not. We used a computational systems biology approach with CellDesigner simulation software to develop a comprehensive graphical map and oscillation loop model for cAMP and Ca(2+). This model indicated that Ca(2+)-mediated inhibition of AC is essential to create oscillations of Ca(2+) and cAMP, and the oscillations were not altered by incorporation of phosphodiesterase-mediated cAMP hydrolysis or PKA-mediated inhibition of AC into the model. More importantly, they were created but faded out immediately in the co-presence of Ca(2+)-noninhibitable AC isoforms. Because the subcellular locations of AC isoforms are different, spontaneous cAMP and Ca(2+) oscillations may occur within microdomains containing only Ca(2+)-inhibitable isoforms in cardiac myocytes, which might be necessary for fine tuning of excitation-contraction coupling.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25585963     DOI: 10.1007/s12576-014-0354-3

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  35 in total

1.  Cloning and characterization of a sixth adenylyl cyclase isoform: types V and VI constitute a subgroup within the mammalian adenylyl cyclase family.

Authors:  S Katsushika; L Chen; J Kawabe; R Nilakantan; N J Halnon; C J Homcy; Y Ishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

2.  Isolation and characterization of a novel cardiac adenylylcyclase cDNA.

Authors:  Y Ishikawa; S Katsushika; L Chen; N J Halnon; J Kawabe; C J Homcy
Journal:  J Biol Chem       Date:  1992-07-05       Impact factor: 5.157

3.  Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress.

Authors:  Satoshi Okumura; Dorothy E Vatner; Reiko Kurotani; Yunzhe Bai; Shumin Gao; Zengrong Yuan; Kousaku Iwatsubo; Coskun Ulucan; Jun-ichi Kawabe; Kaushik Ghosh; Stephen F Vatner; Yoshihiro Ishikawa
Journal:  Circulation       Date:  2007-09-24       Impact factor: 29.690

4.  Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling.

Authors:  Tong Tang; Mei Hua Gao; N Chin Lai; Amy L Firth; Toshiyuki Takahashi; Tracy Guo; Jason X-J Yuan; David M Roth; H Kirk Hammond
Journal:  Circulation       Date:  2007-12-10       Impact factor: 29.690

5.  Calcium oscillations increase the efficiency and specificity of gene expression.

Authors:  R E Dolmetsch; K Xu; R S Lewis
Journal:  Nature       Date:  1998-04-30       Impact factor: 49.962

6.  Modeling and simulation using CellDesigner.

Authors:  Yukiko Matsuoka; Akira Funahashi; Samik Ghosh; Hiroaki Kitano
Journal:  Methods Mol Biol       Date:  2014

7.  Regulation of adenylyl cyclase by protein kinase A.

Authors:  G Iwami; J Kawabe; T Ebina; P J Cannon; C J Homcy; Y Ishikawa
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

Review 8.  New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: effects of targeted disruption of the type 5 adenylyl cyclase gene.

Authors:  Satoshi Okumura; Sayaka Suzuki; Yoshihiro Ishikawa
Journal:  J Pharmacol Sci       Date:  2009-03-07       Impact factor: 3.337

9.  Robustness of self-organizing chemoattractant field arising from precise pulse induction of its breakdown enzyme: a single-cell level analysis of PDE expression in Dictyostelium.

Authors:  Noritaka Masaki; Koichi Fujimoto; Mai Honda-Kitahara; Emi Hada; Satoshi Sawai
Journal:  Biophys J       Date:  2013-03-05       Impact factor: 4.033

Review 10.  Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains.

Authors:  Debbie Willoughby; Dermot M F Cooper
Journal:  Physiol Rev       Date:  2007-07       Impact factor: 37.312

View more
  11 in total

1.  Effects of food diameter on bite size per mouthful and chewing behavior.

Authors:  Kouichi Shiozawa; Yoshiki Ohnuki; Yasumasa Mototani; Daisuke Umeki; Aiko Ito; Yasutake Saeki; Nobuhiro Hanada; Satoshi Okumura
Journal:  J Physiol Sci       Date:  2016-01       Impact factor: 2.781

2.  Arrhythmogenic effect of androgens on the rat heart.

Authors:  Mariana Argenziano; Gisela Tiscornia; Rosalia Moretta; Leonardo Casal; Constanza Potilinski; Carlos Amorena; Eduardo Garcia Gras
Journal:  J Physiol Sci       Date:  2016-05-30       Impact factor: 2.781

Review 3.  Unknown biological effects of L-glucose, ALA, and PUFA.

Authors:  Katsuya Yamada; Daisuke Sato; Takao Nakamura; Hizuru Amano; Yuji Morimoto
Journal:  J Physiol Sci       Date:  2017-05-30       Impact factor: 2.781

4.  Differences in the control of basal L-type Ca(2+) current by the cyclic AMP signaling cascade in frog, rat, and human cardiac myocytes.

Authors:  Rimantas Treinys; Andrius Bogdelis; Lina Rimkutė; Jonas Jurevičius; Vytenis Arvydas Skeberdis
Journal:  J Physiol Sci       Date:  2015-12-16       Impact factor: 2.781

5.  Investigating β-adrenergic-induced cardiac hypertrophy through computational approach: classical and non-classical pathways.

Authors:  Ali Khalilimeybodi; Alireza Daneshmehr; Babak Sharif-Kashani
Journal:  J Physiol Sci       Date:  2017-07-03       Impact factor: 2.781

6.  Mechanisms of astrocytic K(+) clearance and swelling under high extracellular K(+) concentrations.

Authors:  Shingo Murakami; Yoshihisa Kurachi
Journal:  J Physiol Sci       Date:  2015-10-27       Impact factor: 2.781

7.  Wogonin Attenuates Isoprenaline-Induced Myocardial Hypertrophy in Mice by Suppressing the PI3K/Akt Pathway.

Authors:  Weichun Qian; Dongsheng Yu; Jia Zhang; Qiaoyun Hu; Chuanfeng Tang; Peiyu Liu; Peng Ye; Xiaoli Wang; Qiu Lv; Minglong Chen; Liang Sheng
Journal:  Front Pharmacol       Date:  2018-08-13       Impact factor: 5.810

8.  Epac activation inhibits IL-6-induced cardiac myocyte dysfunction.

Authors:  Huiling Jin; Takayuki Fujita; Meihua Jin; Reiko Kurotani; Yuko Hidaka; Wenqian Cai; Kenji Suita; Rajesh Prajapati; Chen Liang; Yoshiki Ohnuki; Yasumasa Mototani; Masanari Umemura; Utako Yokoyama; Motohiko Sato; Satoshi Okumura; Yoshihiro Ishikawa
Journal:  J Physiol Sci       Date:  2016-12-19       Impact factor: 2.781

9.  Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.

Authors:  Daisuke Umeki; Yoshiki Ohnuki; Yasumasa Mototani; Kouichi Shiozawa; Kenji Suita; Takayuki Fujita; Yoshiki Nakamura; Yasutake Saeki; Satoshi Okumura
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

10.  Role of phosphodiesterase 4 expression in the Epac1 signaling-dependent skeletal muscle hypertrophic action of clenbuterol.

Authors:  Yoshiki Ohnuki; Daisuke Umeki; Yasumasa Mototani; Kouichi Shiozawa; Megumi Nariyama; Aiko Ito; Naoya Kawamura; Yuka Yagisawa; Huiling Jin; Wenqian Cai; Kenji Suita; Yasutake Saeki; Takayuki Fujita; Yoshihiro Ishikawa; Satoshi Okumura
Journal:  Physiol Rep       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.